Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERON THERAPEUTICS, INC. /DE/ Director's Dealing 2012

Sep 24, 2012

33572_dirs_2012-09-24_2de9e75e-601d-4b81-822b-69689c49e3ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-25

Reporting Person: SPCH, LLLP (10% Owner)
Reporting Person: Midler Andrew R (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock $0.010 par value 36190476 Direct
Common Stock $0.010 Par Value 1904762 Indirect